Literature DB >> 15124676

Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).

A Hochhaus1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15124676     DOI： 10.1007/s00277-004-0850-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

1.  N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy.

Authors:  Hetian Lei; Gisela Velez; Jing Cui; Arif Samad; David Maberley; Joanne Matsubara; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 2.  Optimal management of metastatic melanoma: current strategies and future directions.

Authors:  Marta Batus; Salman Waheed; Carl Ruby; Lindsay Petersen; Steven D Bines; Howard L Kaufman
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

Review 3.  Epidermal growth factor receptor mutations in lung adenocarcinoma.

Authors:  Markus D Siegelin; Alain C Borczuk
Journal:  Lab Invest       Date:  2013-12-30       Impact factor: 5.662

4.  Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines.

Authors:  R F Rodrigues; L Roque; T Krug; V Leite
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

5.  A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  J F Seymour; D W Kim; E Rubin; A Haregewoin; J Clark; P Watson; T Hughes; I Dufva; J L Jimenez; F-X Mahon; P Rousselot; J Cortes; G Martinelli; C Papayannidis; A Nagler; F J Giles
Journal:  Blood Cancer J       Date:  2014-08-15       Impact factor: 11.037

6.  MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer.

Authors:  Wenqing Qi; Larry S Cooke; Amy Stejskal; Christopher Riley; Kimiko Della Croce; Jose W Saldanha; David Bearss; Daruka Mahadevan
Journal:  BMC Cancer       Date:  2009-05-11       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.